Phase II Study of Celecoxib with Cisplatin Plus Etoposide in Extensive-Stage Small Cell Lung Cancer

By Araujo Antonio   Mendez Jose   Coelho Ana   Sousa Berta   Barata Fernando   Figueiredo Ana   Amaro Teresina   Azevedo Isabel   Soares Marta  

Cancer Investigation, Vol. 27, Iss. 4, 2009-05 ,pp. : 391-396

Informa Healthcare

Access to resources Recommend Favorite

A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer

By Mori K.   Hirose T.   Machida S.   Yokoyama K.   Tominaga K.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 503-505

Elsevier

Access to resources Recommend Favorite

Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer

By Mori Kiyoshi   Kamiyama Yukari   Kondo Tetsuro   Kano Yasuhiko   Tominaga Keigo  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 129-132

Springer Publishing Company

Access to resources Recommend Favorite

Combination of Cisplatin and Interferon- 2a (Roferon(R)-A) in Patients with Non-small Cell Lung Cancer (NSCLC). An Open Phase II Multicentre Study

By Kataja V.   Yap A.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 35-40

Elsevier

Access to resources Recommend Favorite

Combination of cisplatin and interferon alfa-2a (Roferon-A) in patients with non small cell lung cancer (NSCLC). An open phase II multicentre study

By  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 1028-1028

Elsevier

Access to resources Recommend Favorite